Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial.

    Mattila E, Anttila VJ, Broas M, Marttila H, Poukka P, Kuusisto K, Pusa L, Sammalkorpi K, Dabek J, Koivurova OP, Vähätalo M, Moilanen V, Widenius T.

    Scand J Infect Dis. 2008;40(9):702-8.PMID: 19086244 [PubMed - indexed for MEDLINE]Related articles

    2.

    A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial.

    Mattila E, Anttila VJ, Broas M, Marttila H, Poukka P, Kuusisto K, Pusa L, Sammalkorpi K, Dabek J, Koivurova OP, Vahatalo M, Moilanen V, Widenius T.

    Scand J Infect Dis. 2008 Apr 7:1-7. [Epub ahead of print]PMID: 18609231 [PubMed - as supplied by publisher]Related articles

    3.

    Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice.

    Vähätalo M, Rönnemaa T, Viikari J.

    Scand J Prim Health Care. 2007 Sep;25(3):147-53.PMID: 17846932 [PubMed - indexed for MEDLINE]Related articles

    4.

    Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.

    Yki-Järvinen H, Juurinen L, Alvarsson M, Bystedt T, Caldwell I, Davies M, Lahdenperä S, Nijpels G, Vähätalo M.

    Diabetes Care. 2007 Jun;30(6):1364-9. Epub 2007 Mar 23.PMID: 17384341 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.

    Yki-Järvinen H, Kauppinen-Mäkelin R, Tiikkainen M, Vähätalo M, Virtamo H, Nikkilä K, Tulokas T, Hulme S, Hardy K, McNulty S, Hänninen J, Levänen H, Lahdenperä S, Lehtonen R, Ryysy L.

    Diabetologia. 2006 Mar;49(3):442-51. Epub 2006 Feb 3.PMID: 16456680 [PubMed - indexed for MEDLINE]Related articles

    6.

    Factors affecting the efficacy of starting insulin treatment in Type 2 diabetic patients. A retrospective evaluation.

    Vähätalo M, Rönnemaa T, Viikari J.

    Scand J Prim Health Care. 2003 Dec;21(4):230-6.PMID: 14695074 [PubMed - indexed for MEDLINE]Related articles

    7.

    Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes.

    Arkkila PE, Kantola IM, Viikari JS, Rönnemaa T, Vähätalo MA.

    Diabet Med. 1996 Sep;13(9):828-33.PMID: 8891458 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dupuytren's disease in type 1 diabetic patients: a five-year prospective study.

    Arkkila PE, Kantola IM, Viikari JS, Rönnemaa T, Vähätalo MA.

    Clin Exp Rheumatol. 1996 Jan-Feb;14(1):59-65.PMID: 8697659 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of doxazosin on insulin sensitivity in hypertensive non-insulin dependent diabetic patients.

    Huupponen R, Lehtonen A, Vähätalo M.

    Eur J Clin Pharmacol. 1992;43(4):365-8.PMID: 1451714 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Finger manifestations of insulin-treated diabetics in Finland]

    Kantola I, Vähätalo M, Rönnemaa T, Viikari J.

    Duodecim. 1988;104(18):1448-53. Finnish. No abstract available. PMID: 3181046 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...